Morgan Stanley’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
Morgan Stanley's REVS Position: Q2 2026 in Review
Morgan Stanley held its Columbia Research Enhanced Value ETF (REVS) position steady in Q2 2026 at 3,019 shares worth $94.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6276.
Morgan Stanley first reported a position in REVS in Q2 2022 and has held it in 17 quarters since. The position peaked at $96.2K in Q4 2025. 37 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- Morgan Stanley held 3,019 shares of Columbia Research Enhanced Value ETF worth $94.9K as of Q2 2026.
- Morgan Stanley left its Columbia Research Enhanced Value ETF share count unchanged in Q2 2026.
- Columbia Research Enhanced Value ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6276 holding.
- Morgan Stanley first reported a position in Columbia Research Enhanced Value ETF in Q2 2022 and has held it in 17 quarters since.
- Morgan Stanley's Columbia Research Enhanced Value ETF position peaked at $96.2K in Q4 2025.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.